• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

victorlv@unimelb.edu.au

Credentials


Position
Honorary (Principal Fellow)
Department of Medicine
Education
Doctorate (Coursework)
University of Buenos Aires
Bachelors Degree
La Barranca/Highlands School
ORCID

0000-0002-5832-9875

A/Prof Victor Villemagne

Honorary (Principal Fellow)
Department of Medicine

1207 Scholarly works
17 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Streamlined resource-efficient plasma amyloid-beta mass spectrometry assay has improved biomarker performance in preclinical Alzheimer’s disease
    DOI: 10.1038/s41467-026-68372-w
  • 2019

    Research grants (ARC, NHMRC, MRFF)

    The AUstralian-multidomain Approach to Reduce Dementia Risk by prOtecting Brain Health With Lifestyle Intervention (AU-ARROW) Study
  • 2019

    Research Grant

    The Prevalence of Alzheimer's Disease Pathology After Traumatic Brain Injury in Veterans and Civilians: A Biomarker Study of Beta-Amyloid and Tau
  • 2016

    Journal article

    Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease
    DOI: 10.1016/j.jalz.2015.12.013
  • 2015

    Journal article

    Phenomenological characterization of memory complaints in preclinical and prodromal alzheimer's disease
    DOI: 10.1037/neu0000156
  • 2013

    Journal article

    Prediction of amyloid-β pathology in amnestic mild cognitive impairment with neuropsychological tests
    DOI: 10.3233/JAD-2012-121315
  • 2010

    Journal article

    Olfactory deficits and amyloid-β burden in Alzheimer's disease, mild cognitive impairment, and healthy aging: A PiB PET study
    DOI: 10.3233/JAD-2010-100696
Victor Villemagne

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    [18F]PI-2620 for TAU PET versus MRI in Frontotemporal Lobar Degeneration (FTLD)
    DOI: 10.1055/s-0046-1818224
  • 2026

    Journal article

    Plasma amyloid-β predicts amyloid-β accumulation in PET A- non-demented participants
    DOI: 10.1177/13872877261422406
  • 2026

    Journal article

    Joint EANM/SNMMI Recommendations on the Use of Tau PET Imaging in Alzheimer’s Disease
    DOI: 10.1016/j.eanmj.2026.100214
  • 2026

    Journal article

    AI-enhanced Centiloid quantification of amyloid PET images
    DOI: 10.1002/alz.71162
  • 2026

    Journal article

    Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scans
    DOI: 10.1016/j.tjpad.2025.100455
  • 2026

    Journal article

    Harmonizing neuropsychological test data across prospective studies
    DOI: 10.1002/alz.71186
  • 2026

    Journal article

    Predicting the progression of MCI and Alzheimer’s disease on structural brain integrity and other features with machine learning
    DOI: 10.1007/s11357-025-01626-5
  • 2025

    Journal article

    Implementation of NIA‐AA Multilevel Tau Staging for Predicting Tau Accumulation and Cognitive Decline in Non‐Demented Individuals
    DOI: 10.1002/alz70856_105613

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224